Nitric Oxide Deficit Drives Intimal Hyperplasia in Mouse ...
ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness...
36
Transcript of ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness...
![Page 1: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/1.jpg)
![Page 2: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/2.jpg)
![Page 3: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/3.jpg)
![Page 4: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/4.jpg)
![Page 5: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/5.jpg)
![Page 6: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/6.jpg)
![Page 7: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/7.jpg)
![Page 8: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/8.jpg)
![Page 9: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/9.jpg)
![Page 10: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/10.jpg)
![Page 11: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/11.jpg)
![Page 12: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/12.jpg)
![Page 13: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/13.jpg)
![Page 14: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/14.jpg)
![Page 15: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/15.jpg)
![Page 16: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/16.jpg)
![Page 17: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/17.jpg)
![Page 18: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/18.jpg)
![Page 19: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/19.jpg)
![Page 20: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/20.jpg)
![Page 21: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/21.jpg)
![Page 22: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/22.jpg)
![Page 23: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/23.jpg)
![Page 24: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/24.jpg)
![Page 25: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/25.jpg)
![Page 26: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/26.jpg)
![Page 27: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/27.jpg)
![Page 28: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/28.jpg)
![Page 29: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/29.jpg)
![Page 30: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/30.jpg)
![Page 31: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/31.jpg)
![Page 32: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/32.jpg)
![Page 33: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/33.jpg)
![Page 34: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/34.jpg)
![Page 35: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/35.jpg)
![Page 36: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574](https://reader033.fdocuments.in/reader033/viewer/2022041507/5e2611993e4346564d223bc8/html5/thumbnails/36.jpg)